SECURECELL
We have been developing innovative solutions in bioprocess control for biotech and pharma for more than 25 years. This expertise and experience provides the fundament for the development of Seraccess, a truly disruptive Diabetes Therapy. We are experts in process analytics, data processing and automation in bioprocess engineering. As an engineering company, we develop turnkey, tailor-made complete solutions for complex tasks around the bioprocess. We rely on our broad experience and on predevelo... ped modular software and hardware concepts. Our venture division radically transforms diabetes treatment. Out technologyis the first and only technology for the treatment of diabetes which communicates and interacts directly with the blood – and is therefore the only solution which can meet the requirements for a true artificial pancreas. By taking away almost all action steps for patients, our technology radically transforms diabetes treatment for a better life.
SECURECELL
Social Links:
Industry:
Biotechnology Diabetes Health Care Medical Device
Founded:
2009-06-11
Address:
Urdorf, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.securecell.ch
Total Employee:
51+
Status:
Active
Contact:
+41447329070
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Austen BioInnovation Institute
Advance Value-Added, Patient-Centered Healthcare Solutions .
ExoVectory
ExoVectory specializes in offering product that allows for systemic administration of oncolytic virus therapy.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Official Site Inspections
http://www.securecell.ch
- Host name: 199.60.103.73
- IP address: 199.60.103.73
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
